156 related articles for article (PubMed ID: 37724635)
1. Prognostic impact of mitosis and necrosis in non-mucinous lung adenocarcinomas and correlation with IASLC grading system.
Serın G; Savaş P; İşgör İŞ; Özdıl A; Mizrak A; Veral A; Nart D
Histol Histopathol; 2024 Jun; 39(6):703-714. PubMed ID: 37724635
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis.
Hegedűs F; Zombori-Tóth N; Kiss S; Lantos T; Zombori T
Histopathology; 2024 Jul; 85(1):51-61. PubMed ID: 38485464
[TBL] [Abstract][Full Text] [Related]
3. Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas.
Zombori T; Sejben A; Tiszlavicz L; Cserni G; Pálföldi R; Csada E; Furák J
Pathol Oncol Res; 2020 Oct; 26(4):2451-2458. PubMed ID: 32564261
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Histopathologic Features in Pulmonary Invasive Mucinous Adenocarcinomas.
Chang WC; Zhang YZ; Lim E; Nicholson AG
Am J Clin Pathol; 2020 Jun; 154(1):88-102. PubMed ID: 32215558
[TBL] [Abstract][Full Text] [Related]
6. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
[TBL] [Abstract][Full Text] [Related]
7. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
[TBL] [Abstract][Full Text] [Related]
8. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
[TBL] [Abstract][Full Text] [Related]
10. Impacts of thoracoscopic surgery and high grade histologic subtypes on spread through air spaces in small stage I lung adenocarcinomas.
Song T; Jiang L; Zhuo Z; Luo J; Alai G; Shen X; Lin Y
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2375-2382. PubMed ID: 31292713
[TBL] [Abstract][Full Text] [Related]
11. Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer.
Han YB; Kim H; Mino-Kenudson M; Cho S; Kwon HJ; Lee KR; Kwon S; Lee J; Kim K; Jheon S; Lee CT; Lee JS; Kook W; Chung JH
Mod Pathol; 2021 Mar; 34(3):549-561. PubMed ID: 33199839
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
13. Relevance and prognostic ability of Twist, Slug and tumor spread through air spaces in lung adenocarcinoma.
Liu A; Sun X; Xu J; Xuan Y; Zhao Y; Qiu T; Hou F; Qin Y; Wang Y; Lu T; Wo Y; Li Y; Xing X; Jiao W
Cancer Med; 2020 Mar; 9(6):1986-1998. PubMed ID: 31970942
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinoma.
Chen S; Ye T; Yang S; Zhao Y; Zhang Y; Huang Q; Wu H; Hu H; Sun Y; Zhang Y; Xiang J; Wang S; Gu Y; Jin Y; Li Y; Chen H
Lung Cancer; 2022 Feb; 164():33-38. PubMed ID: 34974223
[TBL] [Abstract][Full Text] [Related]
15. High grade tumor budding is associated with poor survival in pathologic stage I lung adenocarcinoma.
Gürçay N; Acar LN; Ünal TDK; Tanrıkulu FB; Biner İU; Bulut S; Baykal H; Demirağ F; Fındık G
Ann Diagn Pathol; 2023 Oct; 66():152188. PubMed ID: 37566939
[TBL] [Abstract][Full Text] [Related]
16. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study.
Zombori T; Furák J; Nyári T; Cserni G; Tiszlavicz L
J Clin Pathol; 2018 Feb; 71(2):135-140. PubMed ID: 28747392
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC/UICC staging system.
Jia M; Yu S; Yu J; Li Y; Gao H; Sun PL
BMC Cancer; 2020 Jul; 20(1):705. PubMed ID: 32727513
[TBL] [Abstract][Full Text] [Related]
20. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
Nomura K; Aokage K; Kaminuma Y; Nakai T; Wakabayashi M; Ikeno T; Koike Y; Taki T; Miyoshi T; Tane K; Samejima J; Ishii G; Tsuboi M
Int J Clin Oncol; 2024 Mar; 29(3):248-257. PubMed ID: 38319510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
